CME Group has filed a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC), challenging the agency’s approval of perpetual futures contracts and setting up a high-stakes legal battle over market structure and regulation.
lawsuit challenges approval of perpetual futures
The case, filed in a federal court in Washington, D.C., names both the CFTC and its chair, Selig, and argues that the regulator unlawfully approved the trading of perpetual futures in the United States. CME claims the decision contradicts definitions established by Congress under federal derivatives law.
According to the complaint, the CFTC approved the first perpetual futures contracts last month for two platforms without following required procedures under the Commodity Exchange Act. CME argues this move directly threatens its core derivatives business by allowing new competitors into markets it already serves.
dispute focuses on classification of contracts
At the center of the case is whether perpetual contracts should be treated as futures or as swaps under the Dodd-Frank Act. Unlike traditional futures, perpetual contracts do not expire and are designed to track asset prices continuously.
CME CEO Terry Duffy has argued these instruments should fall under the swap category, which would subject them to stricter regulatory requirements introduced after the 2008 financial crisis. He has also confirmed plans to step down from the company in 2027.
The distinction carries significant implications, determining how the products are regulated, traded, and who can offer them in the U.S. market.
regulator and industry push back
The CFTC rejected CME’s claims, calling the lawsuit an attempt to resist regulatory modernization. In a statement, the agency said it intends to seek dismissal of the case.
Meanwhile, the Hyperliquid Policy Center criticized CME’s move, describing it as an effort to curb emerging competition. The group noted that perpetual futures are the first new type of derivatives contract to enter regulated U.S. venues in over a decade, adding that exchanges benefit when rules promote open competition.
broader market impact and uncertainty
The legal challenge introduces uncertainty for traders, particularly around the legitimacy of newly approved perpetual contracts. A prolonged court process could slow adoption, especially among participants sensitive to regulatory risk.
If CME prevails, trading of these instruments could be halted or forced into a different regulatory framework, potentially reshaping how they are accessed in the U.S.
The case also highlights the scale of the global perpetual futures market, which has generated massive trading volumes in recent years, often surpassing traditional futures for the same assets. Bringing that activity into the U.S. regulatory system is a key objective for the CFTC, but now faces judicial scrutiny.
clash over market evolution
This dispute underscores a broader conflict between established exchanges and regulators seeking to introduce new products. CME argues the CFTC bypassed a more rigorous approval process by classifying perpetual contracts as futures, while the agency maintains it acted within its authority.
The outcome will likely influence not just the future of perpetual contracts in the United States, but also how quickly new financial products can be integrated into regulated markets.
Want to understand these disputes better? Learn the mechanics behind them in what are perpetuals and how do they work.
Disclaimer: The content on this page is provided for general informational purposes only and does not represent the views or financial advice of Toobit. We make no guarantees regarding the accuracy or completeness of this information and shall not be held liable for any errors, omissions, or outcomes resulting from its use. Investing in digital assets involves risk; users should independently evaluate their financial situation and the risks involved. For further details, please consult our Terms of Service and Risk Disclosure.
